tically significant. The reported data are represented as the mean and standard deviation unless otherwise specified.
RESULTS

Seven
of the eight patients completed both phases of the study.
One patient withdrew from the study secondary to development of a rash after ciprofloxacin administration.
All subjects were compliant with the ciprofloxacin regimen as assessed by patient questioning. The mean serum quinidine concentration versus time profile for each phase is presented in Figure  1 . The pharmacokinetic data for each subject are summarized in the 
